about
Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey.Herpes zoster in kidney transplant recipients: protective effect of anti-cytomegalovirus prophylaxis and natural killer cell count. A single-center cohort study.Impact of anti-HCV direct antiviral agents on graft function and immunosuppressive drug levels in kidney transplant recipients: a call to attention in the mid-term follow-up.Association between baseline serum hepcidin levels and infection in kidney transplant recipients: Potential role for iron overload.Post-transplant hypocomplementemia: A novel marker of cardiovascular risk in kidney transplant recipients?Monitoring of alphatorquevirus DNA levels for the prediction of immunosuppression-related complications after kidney transplantationImpact of MBL2 gene polymorphisms on the risk of infection in solid organ transplant recipients: a systematic review and meta-analysisRisk of infection associated with anti-TNF-α therapyPredictive tools to determine risk of infection in kidney transplant recipientsPrevention and therapy of viral infections in patients with solid organ transplantationOral fosfomycin for the treatment of lower urinary tract infections among kidney transplant recipients-Results of a Spanish multicenter cohortTorque Teno virus load as a surrogate marker for the net state of immunosuppression: The beneficial side of the viromeCOVID-19: A global transplant perspective on successfully navigating a pandemicCandidemia in solid organ transplant recipients in Spain: Epidemiological trends and determinants of outcomeVitamin D deficiency and infection risk in kidney transplant recipients: A single-center cohort studyCOVID-19 in solid organ transplant recipients: a single-center case series from SpainEarly kinetics of Torque Teno virus DNA load and BK polyomavirus viremia after kidney transplantationPredictors of mortality in solid organ transplant recipients with bloodstream infections due to carbapenemase-producing Enterobacterales: The impact of cytomegalovirus disease and lymphopeniaMonitoring of CMV-specific cell-mediated immunity with a commercial ELISA-based interferon-γ release assay in kidney transplant recipients treated with antithymocyte globulinCOVID-19 In Spain: Transplantation In The Midst Of The PandemicVaried clinical presentation and outcome of SARS-CoV-2 infection in liver transplant recipients: initial experience at a single center in Madrid, Spain
P50
Q39296120-245031E8-F402-4C69-A19A-CF3830F979AEQ41994978-93342D79-8572-4073-B871-771775A8DC19Q47550499-EDAC85DC-ED06-4E32-B311-FC17C2E82161Q48334482-02843F71-FFA1-4F8A-A482-2FE9852675D7Q50174777-CD5CE9DB-A179-431A-9B70-7A65F7340278Q57800630-C5A83F9F-A400-48D9-85C4-929F60669E48Q58086161-4C19F92E-562A-4919-9FBC-3C25CB056E15Q58616240-AF2E49D6-871E-44F6-A1A7-B1789F83C3DFQ89831404-ADC28B66-AA9C-49E8-8BE4-7DD79F75BB9BQ90116107-B5191649-17C2-46A0-99C3-3F776243230DQ90255858-3B303022-A4DD-4030-A4DF-8659A42E52BDQ90442227-DF74F639-C54A-4383-92B1-01BBF8D2B0FCQ90581553-5F3922AE-8F5D-45BF-8F79-6D5D60F4C779Q90694883-A8E5D343-CD28-4061-B64C-DE3566875271Q91311347-3C7FCAB7-5579-4C9F-B5F7-F375AECCC287Q92006962-6E787C67-38C1-4472-A3F1-5850C3420985Q92293678-F79C146C-E72A-4B74-BE0C-4882D3C6BE46Q92348908-45E63417-32AB-471E-A8C7-7348B9EF4F59Q92996636-BCF1FFC2-ED4B-4B0F-ABBB-3E7FA63920ADQ94486593-5A0A21BA-B74D-4B39-8DBF-B7397F53EA06Q96612755-296AE51C-B17A-4674-8498-878F1E21B879
P50
description
researcher ORCID ID = 0000-0002-0315-8001
@en
wetenschapper
@nl
name
Mario Fernández-Ruiz
@ast
Mario Fernández-Ruiz
@en
Mario Fernández-Ruiz
@es
Mario Fernández-Ruiz
@nl
type
label
Mario Fernández-Ruiz
@ast
Mario Fernández-Ruiz
@en
Mario Fernández-Ruiz
@es
Mario Fernández-Ruiz
@nl
prefLabel
Mario Fernández-Ruiz
@ast
Mario Fernández-Ruiz
@en
Mario Fernández-Ruiz
@es
Mario Fernández-Ruiz
@nl
P106
P21
P31
P496
0000-0002-0315-8001